FRANKFURT— Bayer AG’s big push into the U.S. agrochemical market with its planned acquisition of Monsanto Co. could help it offset a growing problem on its home turf: increasingly stringent European regulation.
AstraZeneca PLC's experimental cancer drug Iressa appears to buy lung-cancer patients a few extra months could mean that some terminally ill people may not live to see it on the market. Iressa has
This city's chandelier-lighted Bentley dealership opened in June with an order of 30 Bentleys and Rolls-Royces, brands of German car maker Volkwagen AG. Already, the dealership has sold 20 of the
British drug company AstroZeneca PLC said an important latestage trail of its experimental cancer drug Iressa was disappointing - a report that sent the company's shares tumbling. AstraZeneca said
Scientists have taken the first steps toward fighting anthrax streptococcus and other infectious bacteria with virus-produced enzymes, exuding the targeted microbes without apparent side effects or
A survey of 140 large U.S. companies finds the vast majority are moving to adopt environmentally cleaner business practices, but most have failed to codify the behavior to protect against potential
A new World Bank study has challenged one of the bank's most cherished ideas about the cirtues of free trade and investment. "Globalization," the study argues, generally widens the income gap between
German scientists reported they successfully used stem cells harvested from patients' own bone marrow to repair or limit the often-debilitating damage caused by heart attacks. The findings are a
The sick are up before the sun. A bricklayer, a policeman, two secretaries,a tax collector, an auto mechanic, two soldiers, a water-meter reader and a college student crowd into the old tuberculosis
The famine in southern Africa has caused some staunch opponents of generically modified food to take a second look. Thousands of tons of genetically modified food has been donated to the region,
China could soon permit production of generic versions of AIDS drugs, following the lead of countries such as India and Brazil that have allowed local companies to make cheaper substitutes for costly
